🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Effect of Instrument-assisted Soft Tissue Mobilization on Functional and Cognitive Abilities in Elderly

RecruitingNAAges 65 Years - 75 YearsAllCairo University
NCT07208630 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

PURPOSE: To determine the effect of Instrument-assisted soft tissue mobilization on functional and cognitive abilities in elderly. BACKGROUND: There is an increased interest in health care with growth of the older population. Instrument-Assisted Soft Tissue Mobilization (IASTM) is a manual therapy technique using specially designed tools to apply pressure and mobilize soft tissues. It has gained attention as a non-invasive intervention that can aid in improving musculoskeletal health and overall function, especially in older adults. Given the aging population and the rise in age-related functional and cognitive decline, there is a pressing need for effective strategies to enhance quality of life in this demographic. In the elderly, musculoskeletal issues, such as reduced muscle flexibility, joint stiffness, and soft tissue restrictions, are common and can severely impact physical func

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * 60 elderly subjects aged range from 65-75 years old will participant in the study from both genders. * had cognitive abilities to understand explanations and instructions * did not take any medication that can affect their balance. Exclusion Criteria: * They neither had sever musculoskeletal disorders * Nor neurological damage related to balance (dizziness, vestibular dysfunction) * Nor orthostatic hypotension * Nor health risk factors.
💊

What it tests

  • Instrument-assisted soft tissue mobilization
  • Traditional physical therapy
📍

Where

1 site
Faculty of physical therapy
Giza, Egypt
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy